Cargando…
Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system
There has been a growing attention on using machine learning (ML) in pharmacovigilance. This study aimed to investigate the utility of supervised ML algorithms on timely detection of safety signals in the Korea Adverse Event Reporting System (KAERS), using infliximab as a case drug, between 2009 and...
Autores principales: | Lee, Jeong-Eun, Kim, Ju Hwan, Bae, Ji-Hwan, Song, Inmyung, Shin, Ju-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436954/ https://www.ncbi.nlm.nih.gov/pubmed/36050484 http://dx.doi.org/10.1038/s41598-022-18522-z |
Ejemplares similares
-
Machine Learning for Detection of Safety Signals From Spontaneous Reporting System Data: Example of Nivolumab and Docetaxel
por: Bae, Ji-Hwan, et al.
Publicado: (2021) -
Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005–2016
por: Kim, Kwan Soo, et al.
Publicado: (2020) -
Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005–2017
por: Yoon, Dongwon, et al.
Publicado: (2020) -
Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
por: Song, Inmyung, et al.
Publicado: (2016) -
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)